These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 6585590
21. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study. Koutinos G, Stathopoulos GP, Dontas I, Perrea-Kotsarelis D, Couris E, Karayannacos PE, Deliconstantinos G. Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656 [Abstract] [Full Text] [Related]
26. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat. Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA. Vascul Pharmacol; 2009 Oct 01; 50(5-6):166-70. PubMed ID: 19344651 [Abstract] [Full Text] [Related]
28. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. Working PK, Newman MS, Sullivan T, Yarrington J. J Pharmacol Exp Ther; 1999 May 01; 289(2):1128-33. PubMed ID: 10215696 [Abstract] [Full Text] [Related]
29. Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin. Steerenberg PA, Vendrik CP, de Jong WH, de Groot G, Fichtinger-Schepman AM, Scheefhals AP, Schornagel JH. Cancer Chemother Pharmacol; 1988 May 01; 22(1):51-7. PubMed ID: 3293840 [Abstract] [Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 422():1-340. PubMed ID: 12616289 [Abstract] [Full Text] [Related]